Methionine Metabolism and Alcoholic Liver Disease
Author Information
Author(s): Halsted Charles H., Medici Valentina
Primary Institution: University of California, Davis
Hypothesis
Ethanol-induced changes in hepatic methionine metabolism contribute to the pathogenesis of alcoholic steatohepatitis (ASH).
Conclusion
The study highlights the central role of aberrant hepatic methionine metabolism in the development of ASH and suggests that while SAM supplementation may prevent ASH in animal models, its clinical efficacy in treating established ASH remains inconclusive.
Supporting Evidence
- Ethanol exposure alters the hepatic methionine cycle, leading to reduced levels of S-adenosylmethionine (SAM).
- Clinical trials showed inconclusive results regarding the effectiveness of SAM in treating alcoholic liver disease.
- Animal models demonstrated that SAM supplementation can prevent the development of alcoholic steatohepatitis.
Takeaway
This study shows that drinking alcohol can mess up how your body processes a nutrient called methionine, which is important for keeping your liver healthy.
Methodology
The study involved clinical trials and experimental models to assess the effects of ethanol on methionine metabolism and the potential therapeutic role of SAM.
Potential Biases
Potential bias due to the small sample size and the short duration of treatment.
Limitations
The study had a relatively short exposure to SAM and a small number of subjects, which may limit the generalizability of the findings.
Participant Demographics
The study included patients with alcoholic liver disease, specifically those with alcoholic steatohepatitis.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website